Abu Dhabi’s M42, known for bringing technology, artificial intelligence and genomics into healthcare, is launching 10XREVIV in partnership with USA-based 10X Health and UK’s REVIV Global.
10XREVIV is a pioneering venture that is set to transform precision health, nutrition, and longevity. It will introduce a one-of-a-kind Precision Nutrition System to the Middle East, a science-backed innovation that unites genetic insights, blood biomarkers, and nutritional science through proprietary AI and deliver hyper-personalised health optimisation.
Launching first in Abu Dhabi, 10XREVIV will position the UAE as a global epicentre of precision health innovation.
M42 unveils global health collaboration
The collaboration will use 10X Precision Nutrition System, a patented life-sciences platform developed over more than a decade by leading biotechnologists and data scientists. Powered by proprietary AI algorithms, the system analyses up to 20 million genetic variations with 99.97 per cent accuracy, integrating DNA, blood chemistry, and lifestyle inputs to map each individual’s unique biological blueprint.
This produces a secure, 400+-page digital health report providing actionable insights across nutrient absorption, metabolic efficiency, inflammation, immune function, cardiovascular health, and longevity pathways.
These insights will then help 10XREVIV translate complex data into clinically validated, precision-based interventions, including:
- 10X Precision Supplements – micro-bead formulations with up to 22 micronutrients optimised for genetic compatibility and bioavailability.
- 10X Precision Weight Management Solutions – targeted carbohydrate and fat modulators calibrated to individual metabolic and genetic profiles.
- Precision IV Therapy – globally patented genetically informed IV protocols, offering bespoke micronutrient infusions delivered exclusively through approved and certified medical facilities.
Albarah El Khani, Chief Operating Officer, Integrated Health Solutions platform at M42, commented: “At M42, we are committed to redefining how healthcare is delivered by integrating AI, data, and life sciences to unlock human potential.
“Our partnership with 10X Health and REVIV Global represents a significant step toward precision-based, predictive and preventive care – where insights from genetics and biomarkers directly inform how we nourish, restore, and optimise the human body.”
The partnership will also introduce a Precision Longevity flagship clinic, conduct a randomised control trial on the impact of IV nutrition on Type 2 Diabetes, and launch a Precision Nutrition training curriculum, enabling medical practitioners to interpret genetic data and apply it in clinical settings to enhance patient outcomes.
Brandon Dawson, Co-Founder, Chairman & CEO of 10X Health, added: “Partnering with M42 & REVIV Global allows us to expand the reach of our proprietary 10X Precision System into one of the most forward-thinking healthcare ecosystems in the world.
“Together, we are creating a new global benchmark for human optimisation — where science, technology, and clinical application converge.”
The partnership integrates REVIV’s global clinical expertise – with more than 2.5 million IV therapies safely administered worldwide – and 10X Health’s biotechnology platform within M42’s AI-driven precision-medicine ecosystem.
Sarah Lomas, CEO & Founder of REVIV Global, said: “REVIV has long been at the forefront of IV-based therapies and global wellness innovation. This alliance with 10X Health and M42 elevates our vision by combining cutting-edge genetics, AI-driven nutrition and world-class clinical delivery.
“We are excited to bring these advanced solutions to the Middle East and help define a future of longevity and precision health.”
Established in 2023 with the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital and Moorfields Eye Hospital Abu Dhabi.